title: Compounding a Problem?
abstract: Allergist-immunologists say a U.S. Pharmacopeia proposal will mess with an allergy treatment system that's worked for more than a century. The revised standards, if adopted, would remove a key exemption separating allergen extract preparations from the stricter requirements of other compounds. Immunologists say the exemption has allowed them to compound allergen extracts in their own offices, and they've done so safely and effectively millions of times a year.
authors.forename: Joey
authors.initials: J
authors.lastname: Berlin
mesh_terms: D000485:Allergens / Q000737:chemistry; D000486:Allergy and Immunology / Q000639:trends; D003955:Diagnostic Tests, Routine; D004339:Drug Compounding / Q000379:methods* / Q000592:standards* / Q000639:trends; D006801:Humans; D007167:Immunotherapy / Q000592:standards; D010602:Pharmacopoeias as Topic; D010818:Practice Patterns, Physicians' / Q000639:trends*; D014481:United States
chemical_list: D000485:Allergens